APIS Assay Technologies Ltd Locations

2 Results

Filter by Name:

APIS Assay Technologies Ltd

Second Floor Citylabs 1.0 Nelson Street Manchester, Greater Manchester, M13 9NQ United KingdomAPIS designs, manufactures, and sells innovative Drug-Linked biomarker assays that improve patient outcomes across a wide range of disease areas. APIS has a strong focus in oncogenomics and pharmacogenomics (PGx) and leverages systems biology, interrogation of multi-OMICs biodata, and deployment of innovative ‘Clickmer’ ligand binding technology, to translate Drug-Linked biomarkers into clinical utility. APIS has deep expertise and capabilities in IVD development of molecular & immune assays for ultimate product realisation as diagnostic tests. In addition, APIS' expertise in bioinformatics and software development is offered as an agile service to our clients, to develop bespoke, end-to-end multi-OMICs solutions and platform development. The three main service workstreams of our business are: 1. Bioinformatics & Biodata Engineering, ML, AI and Software Development Solutions. - Bespoke NGS Bioinformatic Pipeline development in Nextflow & CWL (RNAseq - sc & bulk; WGS; WES; proteomics) - Experts in Single Cell Omics: data processing, analysis & visualisation - Multi-OMICs data analysis platform development - Biomarker Discovery (Biostatistics, ML and AI) - In silico R&D and bespoke visualisation tools - Clinical Diagnostic consensus variant and copy number calling algorithms and reports - in silico retrospective clinical trial simulations utilising RWD/E for novel cohort stratification - Gene & Cell therapy vector integration (VISA) pipeline development (CAR T) 2. Clickmers - next-generation antibody analogue tools that enable researchers to overcome the limitations of antibody-based technology. - We can develop selective research tools that can be applied to multiple applications including: - IHC, flow cytometry, ELISA, biosensor, PET imaging - Targeted therapeutic delivery and therapeutics - Bioprocessing, purification and pulldown - Target types can include protein, small molecule, cells, tissue, viral vectors, virus and bacteria. - We can also include full assay development, should this be required. 3. Contract Development of novel Molecular Diagnostic (MDx) Assay Development on medical diagnostic platforms. - Operating under an ISO 13485 QMS and supported by the necessary clinical & compliance teams we have expertise in developing NGS, PCR (RT-qPCR, qPCR, dPCR) and ELISA & ELONA IVD tests. Our onsite microbiology facilities mean we have the capabilities to develop infectious disease diagnostic tests in-house. - APIS offers complete end-to-end contract development solutions covering the entire development pipeline including prototype, pilot and commercial lot manufacturing. This also includes expertise in designing, managing, and documenting global infectious disease Clinical Performance studies under CE-IVDR, UKCA and FDA (510K) requirements.

APIS Assay Technologies Ltd

Karnedzijeva 3/2 Belgrade, Serbia, 11060 SerbiaAPIS designs, manufactures, and sells innovative Drug-Linked biomarker assays that improve patient outcomes across a wide range of disease areas. APIS has a strong focus in oncogenomics and pharmacogenomics (PGx) and leverages systems biology, interrogation of multi-OMICs biodata, and deployment of innovative ‘Clickmer’ ligand binding technology, to translate Drug-Linked biomarkers into clinical utility. APIS has deep expertise and capabilities in IVD development of molecular & immune assays for ultimate product realisation as diagnostic tests. In addition, APIS' expertise in bioinformatics and software development is offered as an agile service to our clients, to develop bespoke, end-to-end multi-OMICs solutions and platform development. The three main service workstreams of our business are: 1. Bioinformatics & Biodata Engineering, ML, AI and Software Development Solutions. - Bespoke NGS Bioinformatic Pipeline development in Nextflow & CWL (RNAseq - sc & bulk; WGS; WES; proteomics) - Experts in Single Cell Omics: data processing, analysis & visualisation - Multi-OMICs data analysis platform development - Biomarker Discovery (Biostatistics, ML and AI) - In silico R&D and bespoke visualisation tools - Clinical Diagnostic consensus variant and copy number calling algorithms and reports - in silico retrospective clinical trial simulations utilising RWD/E for novel cohort stratification - Gene & Cell therapy vector integration (VISA) pipeline development (CAR T) 2. Clickmers - next-generation antibody analogue tools that enable researchers to overcome the limitations of antibody-based technology. - We can develop selective research tools that can be applied to multiple applications including: - IHC, flow cytometry, ELISA, biosensor, PET imaging - Targeted therapeutic delivery and therapeutics - Bioprocessing, purification and pulldown - Target types can include protein, small molecule, cells, tissue, viral vectors, virus and bacteria. - We can also include full assay development, should this be required. 3. Contract Development of novel Molecular Diagnostic (MDx) Assay Development on medical diagnostic platforms. - Operating under an ISO 13485 QMS and supported by the necessary clinical & compliance teams we have expertise in developing NGS, PCR (RT-qPCR, qPCR, dPCR) and ELISA & ELONA IVD tests. Our onsite microbiology facilities mean we have the capabilities to develop infectious disease diagnostic tests in-house. - APIS offers complete end-to-end contract development solutions covering the entire development pipeline including prototype, pilot and commercial lot manufacturing. This also includes expertise in designing, managing, and documenting global infectious disease Clinical Performance studies under CE-IVDR, UKCA and FDA (510K) requirements.

DataDiscover

DataDiscover is an AI powered drug discovery startup that aims to speed up the drug discovery process via its platform.

High Throughput Screening for promising hit compounds

Hit identification service using pharma origin, 1.5 million, high-quality, and diverse library. More than 90% hit rates.

Answer the Questions at the Cutting Edge

A precision DNA & RNA synthesis platform for cutting-edge advanced therapeutic research. Dare to Discover.

Are your nonclinical data relevant for the assessment of human immune responses to drugs?

Detect responses difficult to assess in plate-based assays & animal models. Bet on the right drug – Contact us today!

About
Learn more

The Contract Research Map is owned and maintained by Scientist.com. It was created to help researchers in the life sciences identify and connect with contract research organizations (CROs) based on geography. Updated nightly, this map features all of the available CROs within our network, so you can order services with a few clicks. Click on a specific country, scroll on the map itself or type into the search bar at the top—there are many ways to find the location and suppliers that you’re looking for. From Argentina to New Zealand, use this map to connect with a CRO near you.

We believe that every researcher across the world should be able to connect with the thousands of global CROs that exist and have the opportunity to work together. Like many industries,the life science supply chain has been disrupted over the last year. But there are many other circumstances such as international customs regulations or sensitive shipping times that create limitations around which countries are feasible to partner with. Sometimes, finding a CRO based in a country that best suits your research needs is imperative. We hope this contract research map allows you to find the right partner in the right place at the right time.

Have questions or feedback? We’d love to help. You can find our FAQs and contact information on the Learn more page.

Interested in connecting with one or more of the contract research organizations listed on this map? By clicking on the company’s name, you will be directed to their supplier profile on the Scientist.com marketplace. Once you set up a marketplace account you can start the ordering process immediately.

What is Scientist.com?

Scientist.com is the world's largest enterprise marketplace for outsourced R&D services. It saves time and money and provides access to innovation while maintaining compliance with an organization’s procurement policies.

How can I use Scientist.com?

Scientist.com has built private, enterprise marketplaces from 24 of the 30 largest pharmaceutical companies, 80+ biotech companies, the US National Institutes of Health (NIH) and numerous other pharma and biotech companies. If you are employed by one of these organizations, you can log in to get started today. If you are unsure about how to get started, you can email our team at support@scientist.com or go to our website www.scientist.comto speak to someone via our live chat.

Why should I place my order through Scientist.com?

Scientist.com is a highly efﬁcient enterprise-wide outsourcing marketplace that makes it possible for research organizations to save time and money, access innovation and ensure compliance. It utilizes a universal legal agreement and AI technologies to enable research like never before. See how comparing proposals and getting 1-on-1 support from our Research Concierge® team will enable you to place more research today.

How do I get my organization listed on the map?

If your CRO isn’t showing up on the map, then please be sure your company profile is up to date in Scientist.com’s Backoffice. After logging in, click the Your Company button in the navigation at the top, and then select the Locations tab.

Information about my organization is incorrect, how do I fix it?

Head over to backoffice.scientist.com to update your supplier profile and information. It may take up to two business days for the updates to be reflected on the map.